Get started
Author

Félix Goutorbe

Observed names: F Goutorbe, F. Goutorbe, Felix Goutorbe, FéLix Goutorbe, Goutorbe, F., Goutorbe, Felix, Goutorbe, Félix
Observed institutions: Centre National de la Recherche Scientifique, Inserm, Université Clermont Auvergne, Institute Mutualiste Montsouris, Centre Hospitalier de la Côte Basque, Centre Hospitalier Universitaire de Clermont-Ferrand, Université de Clermont I
OpenAlex ID: A5014510815
Diffusion-Weighted Magnetic Resonance Imaging in Ileocolonic Crohn's Disease: Validation of Quantitative Index of Activity
2013 · C Hordonneau, A Buisson, et al. · The American Journal of Gastroenterology · 216
Systematic Review With Meta-Analysis: Anti-TNF Therapy in Refractory Pouchitis and Crohn’s Disease-Like Complications of the Pouch After Ileal Pouch-Anal Anastomosis Following Colectomy for Ulcerative Colitis
2018 · Mathilde Huguet, Bruno Pereira, et al. · Inflammatory Bowel Diseases · 106
Safety of ustekinumab or vedolizumab in pregnant inflammatory bowel disease patients: a multicentre cohort study
2020 · Pauline Wils, Philippe Seksik, et al. · Alimentary Pharmacology & Therapeutics · 74
Oral Curcumin No More Effective Than Placebo in Preventing Recurrence of Crohn's Disease After Surgery in a Randomized Controlled Trial
2019 · Gilles Bommelaer, David Laharie, et al. · Clinical Gastroenterology and Hepatology · 64
Myenteric plexitis is a risk factor for endoscopic and clinical postoperative recurrence after ileocolonic resection in Crohn's disease
2016 · Stéphanie Decousus, Anne-Laure Boucher, et al. · Digestive and Liver Disease · 55
Fecal Matrix Metalloprotease-9 and Lipocalin-2 as Biomarkers in Detecting Endoscopic Activity in Patients With Inflammatory Bowel Diseases
2017 · Anthony Buisson, Emilie Vazeille, et al. · Journal of Clinical Gastroenterology · 53
Comparative efficacy and safety of vedolizumab and infliximab in ulcerative colitis after failure of a first subcutaneous anti‐TNF agent: a multicentre cohort study
2020 · Marianne Hupé, Pauline Rivière, et al. · Alimentary Pharmacology & Therapeutics · 49
Faecal chitinase 3‐like 1 is a reliable marker as accurate as faecal calprotectin in detecting endoscopic activity in adult patients with inflammatory bowel diseases
2016 · A. Buisson, E. Vazeille, et al. · Alimentary Pharmacology & Therapeutics · 48
PDF
Comparative Acceptability of Therapeutic Maintenance Regimens in Patients With Inflammatory Bowel Disease: Results From the Nationwide ACCEPT2 Study
2022 · Anthony Buisson, Mélanie Serrero, et al. · Inflammatory Bowel Diseases · 46
Bowel wall healing assessed using magnetic resonance imaging predicts sustained clinical remission and decreased risk of surgery in Crohn’s disease
2018 · Anthony Buisson, Constance Hordonneau, et al. · Journal of Gastroenterology · 46
Early Transmural Response Assessed Using Magnetic Resonance Imaging Could Predict Sustained Clinical Remission and Prevent Bowel Damage in Patients with Crohn’s Disease Treated with Anti-Tumour Necrosis Factor Therapy
2020 · L Messadeg, C Hordonneau, et al. · Journal of Crohn s and Colitis · 44
Medical Therapies for Stricturing Crohn’s Disease: Efficacy and Cross-Sectional Imaging Predictors of Therapeutic Failure
2017 · Cécile Campos, Antoine Perrey, et al. · Digestive Diseases and Sciences · 43
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease
2022 · Laurent Peyrin-Biroulet, Jean-François Rahier, et al. · Clinical Gastroenterology and Hepatology · 42
PDF
Endoscopic Factors Influencing Fecal Calprotectin Value in Crohn’s Disease
2015 · F. Goutorbe, M. Goutte, et al. · Journal of Crohn s and Colitis · 42
The IBD-disk Is a Reliable Tool to Assess the Daily-life Burden of Patients with Inflammatory Bowel Disease
2020 · Sara Tadbiri, Maria Nachury, et al. · Journal of Crohn s and Colitis · 35
PDF
Clinical guidelines for the management of inflammatory bowel disease: Update of a French national consensus
2020 · Aurélien Amiot, Guillaume Bouguen, et al. · Digestive and Liver Disease · 35
PDF
Faecal calprotectin and magnetic resonance imaging in detecting Crohn’s disease endoscopic postoperative recurrence
2018 · Pierre Baillet, Guillaume Cadiot, et al. · World Journal of Gastroenterology · 35
PDF
Effectiveness and safety of anti-TNF therapy for inflammatory bowel disease in liver transplant recipients for primary sclerosing cholangitis: A nationwide case series
2018 · Romain Altwegg, Roman Combes, et al. · Digestive and Liver Disease · 34
Diffusion-weighted magnetic resonance enterocolonography in predicting remission after anti-TNF induction therapy in Crohn's disease
2015 · Anthony Buisson, Constance Hordonneau, et al. · Digestive and Liver Disease · 31
Top-down infliximab plus azathioprine versus azathioprine alone in patients with acute severe ulcerative colitis responsive to intravenous steroids: a parallel, open-label randomised controlled trial, the ACTIVE trial
2024 · Aurelien Amiot, Philippe Seksik, et al. · Gut · 29
Combined evaluation of biomarkers as predictor of maintained remission in Crohn’s disease
2019 · Elisa Sollelis, Régine Minet Quinard, et al. · World Journal of Gastroenterology · 27
PDF
Impact of HIV Infection on the Course of Inflammatory Bowel Disease and Drug Safety Profile: A Multicenter GETAID Study
2020 · Lucas Guillo, Mathieu Uzzan, et al. · Clinical Gastroenterology and Hepatology · 24
PDF
Development and Validation of a Score to Assess Transmural Healing and Response in Patients With Crohn’s Disease
2024 · Anthony Buisson, Jérémy Junda, et al. · Clinical Gastroenterology and Hepatology · 23
Prevalence and Determinants of Fatigue in Patients with IBD: A Cross-Sectional Survey from the GETAID
2023 · Aurelien Amiot, Sayma Chaibi, et al. · Journal of Crohn s and Colitis · 22
PDF
Effectiveness and Safety of a Second JAK Inhibitor in Ulcerative Colitis: The J2J Multicentre Study
2025 · Mathilde Osty, Romain Altwegg, et al. · Alimentary Pharmacology & Therapeutics · 16
Works count: 87
Citation count: 1,341
H-index: 23
I10-index: 30
Year
Topic
Type